Antibiotics can treat many infectious diseases in our day; however, treatment with many antibiotics that should be effective has failed due to the resistance developed by the microorganisms against the antibiotics (13) .
The emergence of strains of multidrug resistant Klebsiella pneumoniae has been reported with increasing frequency in several countries worldwide, especially those producing extended spectrum beta-lactamases (ESBL) associated with the prior use of antibiotics, particularly cephalosporin (4) .
ESBLs are enzymes that can hydrolyze oxyiminocephalosporins and can be inhibited by clavulanic acid (14) . There have been many methods established to identify ESBL-generating bacteria. The tests used in this regard include a double-disk synergy test, a three-dimensional test, an E-test, searching for ceftazidime resistance, using higher bacteria density, a combined disk method, and applying narrower resistance limits. There also other methods that are used less frequently such as disk diffusion in a clavulanic acid medium, minimal inhibitor concentration in combination with clavulanic acid, and the automated VITEK system. There are some studies investigating ESBL frequency in Turkey and around the world, but the VITEK method is not yet frequently used.
The VITEK 2 advanced expert system (AES) is an automated system that uses antimicrobial susceptibility data to suggest the phenotype of the tested isolate and thereby determine its susceptibility or resistance to antibiotics (15) .
The VITEK 2 system provides two different identification tools. The first includes the analysis and interpretation of the minimal inhibitory concentration (MIC) of several beta lactams using the AES software. The second test is based on simultaneous detection and assessment of the antibacterial activity of cefepime, cefotaxime, and ceftazidime (16) .
The present study aims to develop a MALDI-TOF MS method for the identification of the genus Klebsiella and species isolated from different sources, and assess the ability of the VITEK 2 AES to recognize resistance phenotypes. The researchers have extended the study to compare VITEK 2 with routine antimicrobial susceptibility testing methods.
Materials and methods

Bacterial strains
A total of 51 environmental and clinical isolates were included in the study. Clinical isolates were isolated from different polyclinic units; only strains st11 and st135 were isolated from the pediatric polyclinic 1 month apart. The strains isolated from potable water are the isolates that were isolated from the same center at different times. There was no epidemiological connection between the environmental samples and the clinical samples. Of the isolates, 46% were isolated from feces, 28% from urine, 22% from potable water, and 4% were isolated from animal stools. Detailed data on the isolates are presented in Table 1 .
Biochemical identification of strains
For the human and animal samples collected with a stool collection container for isolation purposes, the cultures were prepared in a manner such that one colony was in EMG agar and incubated for 48 h at 37 °C. The suspected mucoid-like colonies growing on the EMG agar were moved to a TSA medium. The potable water samples were collected in sterile plastic bottles containing 300 mL of 6 mg thiosulfate. A 100 mL volume of each water sample was filtered through cellulose nitrate filters with a pore size of 0.45 µm by using the vacuum in a membrane filtration device (Sartorius, Gottingen, Germany). Then, the filters were placed into Endo's medium (Sartorius, Gottingen, Germany) and incubated for 48 h at 37 °C. The suspected colonies growing on the medium were moved to a TSA medium. In the study, the bacteria that were in the shape of gram-negative bacilli, oxidase-negative, catalase-positive, non-motile, capsular, DNase-negative, and fermentative among the isolates from the urine and feces of individuals with urinary tract infections and the potable water samples were identified as Klebsiella spp. Species-level identification was conducted using the IMVIC (indole, methyl red, Voges-Proskauer, and citrate), urease, lysine decarboxylase, and lactose fermentation tests.
MALDI-TOF mass spectrometry
Following the phenotype-based identification, all strains were also identified using the VITEK MS MALDI-TOF system. In the VITEK MS system, a small amount of bacteria taken from the isolated colonies in the medium plaques using a disposable 1-µL loop was inoculated as a thin layer into the separated areas on single-use target slides (bioMérieux, France). Then, 1 µL of α-cyano-4-hydroxy cinnamic acid (CHCA) matrix solution (bioMérieux, France) was added to the inoculated bacteria and air-dried. The inoculated yeast isolates were first covered with 0.5 µL of formic acid, air-dried, and then covered with 1 µL of matrix and air-dried again. The prepared slides were processed in the VITEK MS device and the obtained spectra were automatically analyzed via the MYLA software (bioMérieux, France). The strains with VITEK MS results compatible with the phenotype identification were considered to be correctly identified (17) . For correct identification of incompatible results, a 16S rRNA sequence was used for the bacteria.
Data analysis
The VITEK MS results were compared with results obtained from amplification and sequencing of a 500-bp region of the 16S rRNA gene performed using an ABI Prism Big Dye Terminator and the recA sequencing was modified following Cesarini et al. (18) . (19) . Escherichia coli ATCC 25922 was used as the negative control strain.
VITEK 2
The isolates were tested on a VITEK 2 automated system using the card AST-N261. Strains were subcultured, and then grown for 18-24 h at 37 °C on a sheep blood agar.
The bacterial isolate to be tested was diluted to a standard concentration (McFarland 0.5) in 0.45% saline and used to load the test cards for the VITEK 2, which was used according to the manufacturer's directions (bioMérieux, France). For the antibiotics on the antibiotic susceptibility test cards and in each antibiotic-containing test well, a signal was automatically measured every 15 min for 18 h. The resulting data were used to generate growth curves and, through comparison to a control, the MIC of each antibiotic was determined. The calculation was done with an algorithm specific for each antibiotic. E. coli ATCC 25922 was used as the negative control.
Results
Bacterial species
The study included 34 clinical isolates from different polyclinics of a single hospital, of which 24 were isolated from feces and 13 from urine, and 51 samples, of which 12 were isolated from potable water and 2 from animal stools. These materials were cultured in sheep blood agar and EMB agar, were identified through classical biochemical tests, and then confirmed via the MALDI-TOF method. As a result of the biochemical tests, all of the isolates were found to be H2S and oxidase negative, and citrate, lysine decarboxylation, and Voges-Proskauer positive. The tests showed that 1.3% of the feces samples and 1.8% of the water samples were indole-positive, and the presence of gas was detected in all samples except 3 urine samples, 1 water sample, and 3 feces samples. All samples, except 3 feces and 2 water samples, were found to be MR positive. All samples, except 1 feces and 1 water sample, were urease negative. All studied samples were non-motile gramnegative bacilli with a capsular structure. The results of all biochemical tests are presented in Table 1 .
Bacterial species with MALDI-TOF MS
The test strains were analyzed by VITEK MS MALDI-TOF and the resulting spectra of their ionizable cell surface components were compared to the spectra in the release database provided with the MALDI-TOF biotyping software. The spectral peaks are shown in the Figure. The findings demonstrated that the VITEK MS system provided the correct results for a diverse group of gramnegative Klebsiella spp. bacteria. Of the samples that were found to be members of the genus Klebsiella by the MALDI-TOF method, 2 samples of potable water (st32 and st33) were detected to be K. oxytoca with a similarity rate of 99%; furthermore, all isolates were found to be K. pneumoniae with a similarity Table 4 .
Discussion
Protein profiling using MALDI-TOF MS was developed during the last decade as an important tool for the identification of microorganisms (20) . Furthermore, it is a powerful method and is sufficiently reproducible and sensitive enough to rapidly survey the evolution of existing or emerging phenotypes with reduced financial and human costs (4 In the current study, the bioMérieux VITEK MS system was able to identify the Klebsiella species with an accuracy of 100%, and the reliability of some results was confirmed by sequencing analysis. Interest in the VITEK 2 automated system has increased due to its minimization of errors, such as indicating false susceptibility for resistant microorganisms, the computer included in its system, its reduction of workload, and its objectivity in evaluation of the results. Its determination of the resistance profile based on MIC values is considered superior compared to the disk diffusion method (24) .
In the current study, the results for the ESBL resistance profile showed a difference between VITEK 2 and the disk diffusion method; the consistency for the genus Klebsiella and species between the two methods was found to be 93.8%. The positivity was detected at a rate of 16.3% with VITEK AES as compared to 4.08% with the disk diffusion method. The VITEK 2 automated system has importance in determining the most proper antibiotic to be administered in treatment, thereby accelerating the treatment. Barry et al. (24) found VITEK 2 results to be consistent with routine resistance tests at a rate of 96.5%, 96.7%, and 95.9%, respectively, for staphylococci, enterococci, and gram-negative bacilli. Canton et al. (25) found the VITEK 2 method less reliable than the microdiffusion method, whereas Leclercq et al. (26) stated that VITEK 2 was more reliable than the agar dilution method. According to Nyberg et al. (27) , sensitivity and specificity vary in different studies, but high sensitivity and specificity have been achieved with VITEK 2 when testing K. pneumoniae isolates (15, 27, 28) . They also claimed that VITEK 2 AES was excellent compared to genotypic ESBL determination and it was very comparable to the agar dilution and diffusion methods.
Furthermore, Nyberg et al. reported that when comparing the results of ESBL positivity, the positive results from the VITEK and agar dilution methods were negative in the disc diffusion method. They found the ESBL test result accuracy of the VITEK 2 method to be 94.4% for K. pneumoniae and 84.0% for K. oxytoca (27) . Livermore et al. (29) demonstrated the capacity of VITEK 2 to detect and interpret resistance mechanisms with a high level of accuracy and standardization. According to Blondel-Hill et al. (30) , the AES system is both adaptable and applicable in clinical microbiology laboratories to enhance the accuracy of susceptibility results and the clinical relevance of therapeutic recommendations.
Numanovic et al. (31) studied the VITEK 2 system on 55 isolates of ESBL-producing Enterobacteriaceae members, including 34 Klebsiella pneumoniae and 3 K. oxytoca isolates, and found that 48 of the 50 genotypically ESBL-producing microorganisms were ESBL positive. That study is consistent with the current study, and shows that it would be appropriate to support the conventional methods with the molecular methods and VITEK in ESBL identification for K. oxytoca isolates.
In conclusion, this study analyzes the different sources of Klebsiella spp. isolates in Turkey using the MALDI-TOF MS technique. We think that this methodology could be used routinely in clinical microbiology laboratories instead of conventional methods for the genus Klebsiella.
Furthermore, antibiotic susceptibility is difficult to detect through conventional methods during the identification of ESBLs, and the molecular methods are time-consuming and expensive for the routine clinical laboratories. The VITEK 2 AES was found to be a successful, reliable, and timesaving system for ESBL identification for the genus Klebsiella.
